Superseded public profile

FDA-approved↗Endocrine↗

Superseded · version 2: Lanreotide↗

Related names recorded in this version: Lanreotide acetate↗

A somatostatin analogue. This profile cites a U.S. label record.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change. 1

What this version reported

The cited DailyMed label identifies Lanreotide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.↗

Organizations named in cited records:
  • U.S. National Library of Medicine↗

Sources for this version

  1. 1
    Lanreotide acetate injection · SPL version 3 · published 2025-06-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026